.jpg)
Founded in 2011, BiOligo is a CRDMO partner and specialized supplier for the RNAi therapeutics and in vitro diagnostics (IVD) industries.
For RNAi therapeutics partners, BiOligo supports OD- to kilogram-scale production with capabilities in super-high purity, ultra-low endotoxin, serving biopharma companies across the R&D lifecycle.
For IVD partners, BiOligo provides primers and probes, enzymes, and NGS reagents, supported by ultra high purity and our Sterile Oligo Synthesis Management Platform for controlled microbial background and consistent quality across molecular diagnostic applications.
TESTIMONIALS
Molecular Diagnostics Solution Company, UK
Having our orders delivered in exact and consistent final yields makes batch planning so much easier! This totally avoids the trouble of order delays or re-orders for us, especially when our products require hundreds of oligos in use.
Oligonucleotide Therapeutics Company, USA
We were working on an intrathecal delivery project, so endotoxin was a big consideration for us. We ordered siRNA from BiOligo, and the endotoxin level came back below 0.01 EU/mg. That was a huge relief and really helped move the project forward. We really appreciated BiOligo’s support.
Biopharmaceutical Company, China
We were really impressed when we first received the siRNA from BiOligo. The purity was 97%, and it arrived in just four days. The experimental yield was also about 10% higher than with other suppliers. That’s when we knew the quality was really there. Since then, BiOligo has become one of our best partners.
Biotechnology Institute, Austria
I was struggling with pathogen samples containing both DNA and RNA, which required separate library builds. I reached out to BiOligo, and they were incredible. In just one month, they developed a custom kit that was not only easy to use but also provided high conversion efficiency and perfect, even coverage for both sample types. It has truly saved me valuable time.
It's our pleasure to support you.
 (1).jpg)
